These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4956073)

  • 1. Lack of carcinogenic activity and metabolic fate of fluorenylacetamides in monkeys.
    Dyer HM; Kelly MG; O'Gara RW
    J Natl Cancer Inst; 1966 Feb; 36(2):305-22. PubMed ID: 4956073
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
    Kriek E
    Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
    [No Abstract]   [Full Text] [Related]  

  • 3. Recovery of radioactivity of N,N'-2,7-fluorenylenebisacetamide-9-C 14 from rats.
    Dyer HM; Lueders KK; Morris HP
    J Natl Cancer Inst; 1967 Jan; 38(1):93-101. PubMed ID: 6016645
    [No Abstract]   [Full Text] [Related]  

  • 4. Modifications of ribonucleic acid by chemical carcinogens. II. In vivo reaction of N-2-acetylaminofluorene with rat liver ribonucleic acid.
    Agarwal MK; Weinstein IB
    Biochemistry; 1970 Feb; 9(3):503-8. PubMed ID: 5415957
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression of enzymic esterification of N-hydroxy-AAF in the liver during aminoazo dye carcinogenesis in the rat.
    Blunck JM; Lees BJ
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):421-9. PubMed ID: 4699475
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of 2-acetamidofluorene in the steppe lemming.
    Weisburger JH; Grantham PH; Weisburger EK
    Br J Cancer; 1965 Sep; 19(3):581-8. PubMed ID: 5833076
    [No Abstract]   [Full Text] [Related]  

  • 7. On protein targets of chemical carcinogens: dissimilar molecular sizes of the principal protein conjugates.
    Sorof S; Young EM; McBride RA; Coffey CB
    Cancer Res; 1970 Jul; 30(7):2029-34. PubMed ID: 4989548
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
    Zieve FJ; Gutmann HR
    Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased selectivity of interaction between fluorenylamine carcinogens and liver proteins during hepatocarcinogenesis.
    Sorof S; Young EM; McBride RZ; Coffey CB; Luongo L
    Mol Pharmacol; 1969 Nov; 5(6):625-39. PubMed ID: 5373894
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide.
    Levine WG
    Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of action of carcinogenic aromatic amides.
    Gutmann HR; Barry EJ; Malejkagiganti D
    J Natl Cancer Inst; 1969 Jul; 43(1):287-91. PubMed ID: 5796392
    [No Abstract]   [Full Text] [Related]  

  • 12. Different action of carcinogenic and noncarcinogenic substances on the proliferative activity of adrenal cortex cells.
    Danz M; Amlacher E; Urban H; Bolck F
    Exp Pathol (Jena); 1973; 8(2):122-7. PubMed ID: 4777262
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities.
    Lower GM; Bryan GT
    Biochem Pharmacol; 1973 Jul; 22(13):1581-8. PubMed ID: 4729805
    [No Abstract]   [Full Text] [Related]  

  • 14. [Improvement of the process of fluorene degradation by Rhodococcus rhodochrous strain 172].
    Rubashko GE; Kolomytseva Mp; Golovleva LA
    Prikl Biokhim Mikrobiol; 2006; 42(4):448-51. PubMed ID: 17022455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of the carcinogen N-2-fluorenylacetamide in germ-free and conventional rats.
    Grantham PH; Horton RE; Weisburger EK; Weisburger JH
    Biochem Pharmacol; 1970 Jan; 19(1):163-71. PubMed ID: 5507634
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleophilic substitution on carcinogenic N-acetoxy-N-arylacetamides.
    Scribner JD; Miller JA; Miller EC
    Cancer Res; 1970 Jun; 30(6):1570-9. PubMed ID: 5457931
    [No Abstract]   [Full Text] [Related]  

  • 17. The carcinogenicity of the o-methoxy derivatives of N-2-fluorenylacetamide and of related compounds in the rat.
    Gutmann HR; Galitski SB; Foley WA
    Cancer Res; 1968 Feb; 28(2):234-44. PubMed ID: 5641517
    [No Abstract]   [Full Text] [Related]  

  • 18. The metabolic activation of carcinogenic aromatic amines and amides.
    Miller JA; Miller EC
    Prog Exp Tumor Res; 1969; 11():273-301. PubMed ID: 4888944
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of aromatic amines with rat liver proteins in vivo. II. Binding of N-2-fluorenylacetamide-9-14C to nuclear proteins.
    Barry EJ; Ovechka CA; Gutmann HR
    J Biol Chem; 1968 Jan; 243(1):51-60. PubMed ID: 5635948
    [No Abstract]   [Full Text] [Related]  

  • 20. Difference in binding of 2-acetylaminofluorene to rat liver deoxyribonucleic acid and ribosomal ribonucleic acid in vivo.
    Kriek E
    Biochim Biophys Acta; 1968 Jun; 161(1):273-5. PubMed ID: 4298436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.